N/A
12.810
To enhance the health, safety, readiness, and performance of Air Force personnel through applied medical research and advanced development executed largely through grants, cooperative agreements, and contracts with civilian educational and research institutions/organizations.
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
“Transition of Advanced Trauma, Hemorrhage and Vascular Injury Products.” This project provides for the development, design, refinement, evaluation, certification and transition of innovative dual-use technologies that will help revolutionize the delivery and efficacy of acute trauma and resuscitative care to patients suffering life threatening illnesses and injuries. The trauma and resuscitative product line is an especially important focus area for military medicine due to the prevalence and nature of injuries and illnesses that affect DoD personnel in performance of their mission responsibilities.
Field Intravenous Expeditionary System – a system to generate Sterile Water for Injection (SWFI) to constitute multiple formulations of intravenous (IV) solutions consisting of ringers lactate, lyophilized human plasma, saline and other sterile fluids and/or biologics and medications Expeditionary Medical Support system (EMEDS) sites. This is being overseen and managed by the prime (Military & Health Research Foundation, MHRF) and executed by the subcontractor (Parker-Hannifin).
Endovascular Variable Aortic Control - a clinically viable catheter with integrated solid-state sensors and a blood pressure monitor that will control blood flow in patients with non-compressible truncal hemorrhage in a way that reduces distal ischemia and organ damage below the balloon when compared to current technologies. This project will result in a completed device ready for verification and validation testing in support FDA 510(k) clearance.
Field Intravenous Expeditionary System – a system to generate Sterile Water for Injection (SWFI) to constitute multiple formulations of intravenous (IV) solutions consisting of ringers lactate, lyophilized human plasma, saline and other sterile fluids and/or biologics and medications Expeditionary Medical Support system (EMEDS) sites.
N/A
N/A
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.